The purpose of this study was to determine whether the Laurus nobilis chloroform fraction (LNCF) protects against cerebral ischemia neuronal damage. Human neuroblastoma SH-SY5Y cells and brain slices from rats were subjected to oxygen and glucose deprivation (OGD), followed by reoxgenation with and without LNCF. The viabilities of SH-SY5Y cells and brain slices from the rats were 58:5 AE 4:9% and 79:7 AE 5:9% in the group subjected to OGD, and 80:4 AE 0:4% and 97:2 AE 1:9% at 4 g/ml of LNCF, respectively. LNCF also significantly inhibited death-associated protein kinase (DAPK) dephosphorylation. Pretreatment with LNCF at 4 mg/kg significantly decreased infarct size by 79% of vehicle control in the middle cerebral artery occlusion (MCAO) in vivo model. LNCF is a neuroprotective drug candidate against cerebral ischemia neuronal damage.
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Cerebral ischemia leads to a reduction in blood flow that deprives the afflicted brain region of oxygen and nutrients. It is associated with complex biochemical and molecular mechanisms that impair neurological functions. 1) According to the deprivation in the brain, a variety of pathological events in the brain trigger ischemic cell death, including delayed neuronal dysfunction, excitotoxicity, ionic imbalance, and inflammation.
2) To date, there is a report that ischemia has also been implicated in Alzheimer's and other neurodegenerative diseases.
3) However, the mechanism responsible for ischemic neuronal death has not been clearly identified, and there is no effective therapy for the treatment of acute ischemic neuronal damage.
Recent studies have shown that death-associated protein kinase (DAPK) is a protein regulated by ischemic conditions both in vitro and in vivo. 4) DAPK is a calcium calmodulin-regulated serine/threonine protein kinase that has been implicated in various apoptotic paradigms induced by a variety of stimuli that are not completely understood, but some reports insisted that there were relationships with pro-and anti-apoptotic proteins, such as p38, Smad, JNK (c-Jun N-terminal kinase), and ERK1/2. [4] [5] [6] DAPK is activated early in the pathway of apoptosis, and there is a report that inhibition of DAPK by aminopyridazine enhances neuronal survival and reduces brain injury. 7) These studies indicate that DAPK is a drug-discovery target in neurodegenerative diseases. 8) Among in vitro models of ischemic-induced injuries, several neuronal cell lines and organotypic hippocampal slices have used oxygen and glucose deprivation (OGD) and reoxygenation. 9, 10) The OGD model represents a valid stimulation of the conditions in brain ischemia and, especially in using hippocampal slices, can maintain similar cell composition in brain damage.
11) Organotypic hippocampal slices are widely used to investigate the neuroprotective effects of compounds 12, 13) and the mechanisms of programmed cell death in hypoxia, because the structure, especially the CA1 regions, is susceptible to ischemia. 14, 15) Similarly, rats with cerebral ischemia used in in vivo studies induced by middle cerebral artery occlusion (MCAO) and reperfusion and MCAO models are widely used in therapeutic studies of ischemic stroke. 16) Human cerebral ischemia normally causes diminished blood flow by a single occlusion of blood vessel, often the middle cerebral artery, hence MCAO can represent a naturally occurring stroke. According to the disruption, glutamate receptors are overactivated and the intracellular calcium concentration is much increased. This is associated with calcium-dependent delayed cell death. Briefly, hypoxia increases glutamates, translocation of calcium from the extracellular to the intracellular region, or activation of proteolytic enzymes. cently, they were reported to have antioxidant activities, using liposomes prepared from bovine brain extract. 21) By screening of medicinal plants, we selected the chloroform fraction of a methanol extract of the leaves of Laurus nobilis (LNCF). The aim of the study was to characterize the neuroprotective effects of LNCF with regard to increases in cell viability via inhibition of the DAPK activation and decreases in the infarct volume of injured brain tissue.
Materials and Methods
Preparation of LNCF. Leaves of Laurus nobilis were imported from Orege Forest Agricultural and Food Products Foreign Trade (Izmir, Turkey). The dried, chopped leaves (500 g) were extracted with methanol 3 times at 40-50 C. The pooled extracts were evaporated in vacuo, and a brown residue (105 g) was obtained. Using the solvent partitioning method, part of that residue was fractioned into n-hexane (9 g), chloroform (24 g), and water (17 g). The chloroform fraction was evaporated to dryness under reduced pressure using a rotary evaporator. The LNCF was then weight to calculate the yield. Oxygen and glucose deprivation plus reoxygenation experiments on SH-SY5Y cells. OGD was performed as described previously. 9) On the second day of differentiation, the cell culture DMEM medium was removed and the cells were washed with glucose-free DMEM and placed in fresh glucose-free DMEM. OGD groups changed to glucosefree DMEM were incubated for 1 h at 37 C in 5% CO 2 for adaptation. After 1 h of adaptation, the cells were treated at a final concentration of 0.16 mg/ml to 4 mg/ml of LNCF or 500 mg/ml carnosine and were adapted another 1 h. Then they were transferred to a hypoxia chamber (Modular Incubator Chamber (MIC-101), Billups-Rothernberg, Del Mar, CA) containing a mixture of 95% N 2 and 5% CO 2 at 37 C for 20 h. For reoxygenation, glucose was added to a final concentration of 4.5 mg/l, followed by incubation for 24 h under normal conditions. 22) In the sham-OGD groups, the cells were incubated with standard high DMEM under normal conditions and were changed to glucose-free DMEM at a final concentration of 4.5 mg/l, as for OGD group reoxygenation.
Flow cytometry measurement of apoptosis. The OGD-induced SH-SY5Y cells were tripsinized as a single cell suspension, collected, and washed 3 times with 1X PBS. Ice-cold 70% ethanol was added to fix the cells, which were kept at À20 C until assay. For the analysis of apoptosis by flow cytometry, cells were recollected by centrifugation and resuspended in PBS, and stained with propidium iodide (PI) (125 mg/ml) at 4 C in the dark for 30 min. Data were obtained with a Coulter Epics XL (Beckman-Coulter, Foullerton, CA). The percentage of apoptosis was estimated from the area corresponding to the sub-G1 population. 23) Preparation of organotypic slice cultures. Adult male SpragueDawley rats were deeply anesthetized with dimethyl ether, and their brains removed rapidly and submerged in a chilled Krebs-Henseleit solution (pre-incubation solution, pH 7.4) of the following composition: 120 mM NaCl, 4 mM NaHCO 3 , 10mM MgSO 4 , 2mM KCl, 1.18 mM KH 2 PO 4 , 0.5 mM CaCl 2 , 25 mM HEPES, and 11 mM glucose, pH 7.4. 15, 24, 25) The brains were cut transversely at 500 mm and were plated onto cell culture inserts (0.4 mm pore PET membrane, BD Biosciences, Oxford, UK) with pre-incubation solution at 37 C in an atmosphere of 95% air-5% CO 2 for 30 min.
OGD followed by reoxygenation. C. For the OGD group, the slices were incubated in an OGD incubation solution and transferred to a hypoxia chamber with a mixture of 95% N 2 and 5% CO 2 at 37 C for 2 h. The LNCF or carnosine were added during the OGD condition. Control group slices were exposed to OGD incubation solution with 11 mM glucose, and were incubated at 37 C in an atmosphere of 5% CO 2 . After the OGD period, the slices were into a new Krebs-Henseleit solution with glucose, like the control group, for an appropriate period of reoxygenation for 2 h.
Analysis of cell viability. For a measurement of cell viability, slices were incubated with 0.5 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) in PBS for 30 min at 37 C. 26) Subsequently, the slices, in sterile tissue culture plate inserts were transferred to a new plate, and formazan was dissolved with 100% dimethyl sulfoxide. Viable cells of slices were quantified spectrophotometrically at 540 nm. The results are shown as percentages of control.
Western blot analysis. SH-SY5Y cells after OGD treatment were lysed, and the ischemic hippocampal slices were homogenized in PRO-PREP protein extraction solution (Intron Biotechnology, Seongnam, Korea). Then the lysates were centrifuged at 13,000 rpm for 15 min at 4 C. After protein preparation, 50 mg of total protein were separated by 10% SDS-PAGE gel eletrophoresis and this was transferred onto polyvinylidene difluoride membranes. The membranes were blocked with 5% skim milk at room temperature for 2 h. Monoclonal anti-DAPK clone (1:250, Sigma-Aldrich, St. Louis, MO), and monoclonal anti-phospho DAPK (pSer 308 , 1:1000, Sigma-Aldrich, USA) were incubated with membranes at 4 C overnight. The membranes were then probed with horseradish peroxidase-confugated goat anti-rabbit IgG as secondary antibodies for 1 h and developed with WEST-oneÔ spray type (Intron Biotechnology, Seongnam, Korea). Immunoreactivity was detected by image analyzer (LAS1000, Fujifilm, Tokyo, Japan), and quantification of signal intensities was done.
Drug preparation and treatment. The rats were randomly divided into four groups: a sham, a vehicle, an LNCF, and a carnosine treated group. LNCF was dissolved in 100% ethanol, and was diluted with saline at final concentrations of 0.2 mg/kg, 1 mg/kg, and 4 mg/kg in 1% ethanol. Carnosine was diluted with 1% ethanol in saline at final concentration of 50 mg/kg. Thirty min before MCAO, the rats were administered intraperitoneally the three concentrations of LNCF and vehicle.
Animals and surgical procedures. All experimental protocols were approved by the Institutional Animal Care and Use Committee of Seoul National University. Focal cerebral ischemia was induced by intraluminal MCAO, as described previously, with slight modifications. 16) In brief, adult male Sprague-Dawley rats weighing 290-310 g were anesthetized with 2-3% isoflurane (AErane Ò , Baxter, Deerfield, IL) in a 30% O 2 :70% N 2 O mixture through a face mask under spontaneous breathing. Rectal temperature was maintained at 37:0 AE 0:5 C with a temperature regulated heating pad. Briefly, the right external carotid artery (ECA), the common carotid artery (CCA), and the internal carotid artery (ICA) branches were isolated from the surrounding nerves, and fascia and coagulated. Then the middle cerebral artery was occluded with a 3-0 poly-L-lysine-coated nylon suture through the extracranial ICA for 1.5 h. Reperfusion was performed by withdrawing the suture when the tip had cleared the ICA and was left in the stump of the CCA. The sham-operated animals received all surgical procedures, but the suture was not introduced.
Neurological deficit score. Neurological deficits were evaluated 24 h after MCAO induction. The scores were on a 5-point scale; no neurological deficit ¼ 0, failure to extended left forepaw fully ¼ 1, circling to the left ¼ 2, falling to the left ¼ 3, and cannot walk spontaneously and shows lower levers of consciousness ¼ 4.
2,3,5-Triphenyltetrazolium chloride staining and determination of infarct volume.
To measure the infarct volume, the brains were removed quickly and sectioned into six coronal sections 2-mm thick by brain matrix (Harvard Bioscience, Holliston, MA). The slices were placed in 24-well plates and stained with 2% 2,3,5-triphenyltetrazolium chloride (TTC), then fixed in buffered 4% paraformaldehyde solution. The infarct areas of all the sections were calculated using digital imaging with a computerized image analyzer. The infarct volumes were expressed as described previously. 27) They were calculated as a percentage of the contralateral hemisphere volume by the indirect method, area of intact contralateral (left) hemisphere minus area of intact regions of the ipsilateral (right) hemisphere, to compensate for edema formation in the ipsilateral hemisphere: 28) I (infarct volume, %) ¼ ðVc À ViÞ=Vc Â 100 ðVc À ViÞ=Vc Â 100%, where Vc is the volume of the intact contralateral (left) hemisphere and Vi the volume of intact regions of the ipsilateral (right) hemisphere.
Statistical analysis. All results are presented as means AE SEM. Statistical significance was determined using Student's t-test. Differences between means are considered significant at 5% level of significance (p < 0:05).
Results

Neuroprotective effects of LNCF against OGD in SH-SY5Y cells
SH-SY5Y cells were exposed to OGD, which causes ischemia-induced cell death, and cell viability was measured under hypoxic conditions. Among the three fractions from L. nobilis, the n-hexane and aqueous fractions did not show protection of neurological cell death during OGD in the SH-SY5Y cells (data not shown). Cells were incubated with LNCF at concentrations of 0.16 mg/ml to 4 mg/ml concentration with OGD treatment, and the cell viability was calculated by PI-staining of cells with compromised membrane integrity.
As shown in Fig. 1 , OGD resulted in viability of 58:5 AE 4:9% in human neuroblastoma cells. Compared with the OGD group, treatment with LNCF increased the neuronal survival rate of the cells in a dosedependent manner.
Treatment with 2 and 4 mg/ml of LNCF significantly increased the neuronal survival rate by 71:2 AE 0:5% and 80:4 AE 0:4% respectively. The lower concentration of LNCF (0.8 mg/ml) exhibited mild effects on neuronal cell death. We also examined carnosine as a positive control, since several studies have demonstrated significant antioxidant and anti-ischemic properties in the brain. 29, 30) As shown in Fig. 1 , the cells were treated 500 mg/ml of carnosine during oxygen-glucose deprivation, and cell viability was 85:6 AE 8:8%.
Cell viability effects of LNCF in hippocampal slices exposed to OGD Acute hippocampal slices were subjected to OGD for 4 h and reoxygenation for 2 h in the absence and the presence of LNCF (0.16-4 mg/ml) or carnosine (500 mg/ml). LNCF at 4 mg/ml significantly increased MTT reduction in the slices exposed to OGD, and the relative MTT reduction values were 92:4 AE 7:8% in the 500 mg/ml carnosine treated group and 97:2 AE 1:9% in the LNCF 4 mg/ml treated group, as compared to control (Fig. 2) . LNCF showed more neuroprotective effects than carnosine in the organotypic hippocampal slices.
Effects of LNCF on the expression of DAPK and p-DAPK in OGD-induced SH-SY5Y cells DAPK expression was examined in SH-SY5Y cells subjected to OGD in the presence of LNCF (0.16-4 mg/ml). When the same amount of total proteins from OGD-induced cells was analyzed for the level of phosphorylated DAPK (p-DAPK), significant dephosphorylation of DAPK was detected in SH-SY5Y cells subjected to 16 h of OGD (Fig. 3A) . The relative intensity of p-DAPK/DAPK in the OGD-induced group decreased by 53:9 AE 0:1%, as compared with control. Hippocampal slices were exposed to OGD for 4 h, followed by 2 h reoxygenation. The data represent the means AE SEM of at least three different experiments. However, OGD-induced cells with 0.8 mg/ml of LNCF inhibited DAPK dephosphorylation significantly as an active form of DAPK and the relative intensity of p-DAPK/DAPK was increased to 83:5 AE 0:2% (Fig. 3B) .
Effects of LNCF on the expression of DAPK and p-DAPK activity in OGD-induced hippocampal slices
To elucidate the neuroprotective mechanisms of LNCF, hippocampal slices were incubated with LNCF (0.16-4 mg/ml), followed by protein extraction and western blot analysis (Fig. 4) . The relative intensity of p-DAPK/DAPK in the OGD-induced hippocampal slices was diminished by 67:8 AE 0:2% as compared with control, but the OGD-induced slices with 0.8 and 4 mg/ml of LNCF significantly inhibited DAPK dephosphorylation, and the relative intensities of p-DAPK/ DAPK significantly increased to 88:2 AE 0:2 and 97:5 AE 0:3% respectively (Fig. 4B) .
Effects of LNCF on neurological deficit score and cerebral infarct size
To determine whether LNCF might be an effect in a rat model of MCAO, rats were injected intraperitoneally with vehicle or LNCF at 0.2 to 4 mg/kg before MCAO.
After MCAO and reperfusion, the neurologic deficit score was determined. The score of the vehicle group was 3:3 AE 0:5 and treatment with 4 mg/kg of LNCF significantly reduced the neurological score, by 3:3 AE 0:5 (Fig. 5) . Fifty mg/kg administered to the carnosine treated group decreased the score by 2:5 AE 0:9. The cerebral infarct volume was significantly decreased and the volume of the LNCF-treated groups was smaller than in the vehicle-treated groups (Fig. 6A) . The infarct size in the vehicle group that was given the saline was 36:9 AE 5:8%, and the infarct size in the carnosine 50 mg/kg treated group was 31:3 AE 6:1% (Fig. 6B) . Maximal reduction of infarct volume was achieved at a dose of 4 mg/kg of LNCF, resulting in an infarct volume of 7:8 AE 3:0%. One and 0.2 mg/kg of LNCF pretreatment reduced the infarct size by 12:2 AE 5:9%, and 32:0 AE 8:2% respectively.
Discussion
Cerebral ischemia results in a reduction in oxygen and glucose supply causing cell death when the blood flow to the brain is interrupted. Previous studies have shown that DAPK is implicated in the molecular response to ischemic brain injury and early apoptosis-mediated cell A, The infarct areas in the various sections of the rat brain were determined by TTC staining. B, The infarct volume was calculated by digital images using a computerized image analyzer. All data are expressed as means AE SEM (n ¼ 7).
ÃÃ p < 0:01 compared to the vehicle group. death in neurons. 4, 8) Hence we decided to identify neuronal cell death inhibition effects of LNCF by regulation of DAPK dephosphorylation.
As shown in Figs. 1 and 2 , LNCF strongly inhibited neuronal death induced by OGD in SH-SY5Y cells and organotypic hippocampal slices. This indicates that LNCF has neuroprotective effects in an in vitro model of ischemia.
Death-associated protein kinase (DAPK) dephosphorylation induced by cerebral ischemia is significantly regulated by LNCF. DAPK has been implicated in regulating early apoptosis induced by a variety of stimuli, including tumor necrosis factor-alpha 31) and Fas. 32) In this study, DAPK was activated by OGD, and the relative intensity of phosphorylated DAPK/DAPK decreased extremely in human neuroblastoma cell line as well as in organotypic slices (Figs. 3 and 4) . This indicates that DAPK exists as an inactive form in normal neuronal cells and is dephosphorylated as an active form response to ischemic brain injury and apoptosismediated cell death. The data from this study indicate that LNCF keeps DAPK in its phosphorylated, inactive form after OGD, and that LNCF significantly prevents OGD-induced neuronal death by inhibition of DAPK dephosphorylation.
LNCF also decreased infarct size in middle cerebral artery occlusion (MCAO) as an in vivo model (Fig. 5) . The middle cerebral artery is the main cause artery in cerebral ischemia, and causes wide infarction of the brain when oxygen and glucose supply is interrupted to the brain. 33, 34) One mg/ml of LNCF significantly decreased infarct size in a MCAO. These results imply the potential therapeutic efficacy of LNCF in ischemic injury and the possibility that LNCF can regulate neuronal death in an MCAO model by reducing the dephosphorylation of DAPK.
As shown in Figs. 4, 5, and 6, LNCF has strong neuroprotective effects in ischemic injury as compared to carnosine, which several studies have demonstrated to protect against neuronal death.
29) Based on these results, LNCF has possibilities as a strong neuroprotective therapeutic drug.
In conclusion, the chloroform fraction of Laurus nobilis significantly ameliorated ischemic neuronal death and also diminished DAPK dephosphorylation in human cell lines and organotypic tissues. The fraction also reduced infarct size and the neurological deficit of MCAO in vivo. Thus the chloroform fraction of Laurus nobilis is a neuroprotective drug candidate for treatment of patients suffering from cerebral ischemia.
